NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-071-2020-0-AU-04 CYCLIC COMPOUNDS FOR USE IN TREATING RETINAL DEGENERATION AU National Stage 2021300425 Pending
NIAID E-150-2021-0-US-01 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST WESTERN, EASTERN, AND VENEZUELAN EQUINE ENCEPHALITIS VIRUS (EVV) US 63/386,488 Expired
NIDA E-183-2021-0-US-02 PROTOCOL TO ENHANCE THERAPEUTIC EFFECTS OF TRANSCRANIAL MAGNETIC STIMULATION US ORD 18/076,071 Pending
NCI E-082-2023-0-EP-01 LIGANDS SPECIFIC FOR ASCT1 EP ORD 22306795.0 Pending
NEI E-028-2023-0-US-01 PIGMENT EPITHELIUM-DERIVED FACTOR PEPTIDES AND USE FOR TREATING RETINAL
DEGENERATION 		US 63/430,251 Expired
NCATS E-169-2019-0-US-03 DIFFERENTIATION OF TROPHECTODERM LINEAGE CELLS FROM PLURIPOTENT STEM CELLS US National Stage 18/000,653 Pending
NIAID E-143-2018-0-JP-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS JP National Stage 2022-574455 Pending
NCI E-142-2022-0-US-01 Topoisomerase Ill (TOP3) inhibitors as antiviral and anticancer compounds based on bisacridines US 63/429,923 Expired
NIAID E-080-2013-0-AU-10 Attenuation of Human Respiratory Syncytial Virus by Genome Scale Codon-Pair Deoptimization AU DIV 2022279509 Issued
NCI E-219-2021-0-PCT-02 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION PCT PCT PCT/US2022/080650 Expired
NIAID E-028-2024-0-US-01 Peptides And Peptide Micro Arrays For Detection And Differentiation Of Antibody Responses To Ebola Virus And Other Pathogens US 63/428,826 Expired
NIAID E-060-2015-0-AU-20 Novel Multivalent Nanoparticle-Based Vaccines AU DIV 2022279441 Pending
NIAID E-208-2023-0-PC-01 HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES PCT PCT PCT/US2022/080588 Expired
NCI E-199-2021-0-PCT-02 COMPOSITIONS FOR INHIBITING DIPEPTIDE REPEAT PROTEIN-RIBOSOMAL RNA INTERACTION AND USES THEREOF PCT PCT PCT/US2022/051249 Expired
NCI E-027-2022-0-US-01 TOPOISOMERASE Ill (TOP3) INHIBITORS AND ANTIVIRAL COMPOUNDS BASED ON CYANINES US 63/428,529 Expired
NCI E-062-2019-3-US-02 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate US CON 18/059,840 Abandoned
NEI E-247-2020-0-US-02 BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTORS AND USE THEREOF US National Stage 18/000,008 Pending
NIAID E-143-2018-0-CA-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS CA National Stage 3185143 Pending
NCI E-265-2015-0-JP-36 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` JP DIV 2022-188263 Issued
NICHD E-039-2015-0-US-20 ADENO-ASSOCIATED VIRUS VECTORS ENCODING MODIFIED G6PC AND USES THEREOF US CON 18/058,457 12440580 Issued PDF
NEI E-165-2017-0-US-05 COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES US DIV 18/058,064 12383554 Issued PDF
NIAID E-228-2016-1-JP-16 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof JP DIV 2022-186724 Issued
NIAID E-001-2024-0-US-04 Viral Strain Serology Assays US 63/384,673 Expired
NCI E-173-2018-2-JP-01 Viral Methods Of T Cell Therapy JP DIV 2022-185536 Pending
NCI E-059-2013-0-JP-25 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor JP DIV 2022-185113 Issued
NIAID E-052-2017-4-MX-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection MX DIV MX/a/2022/014631 Abandoned
NIAID E-238-2020-0-PCT-02 EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3) PCT PCT PCT/US2022/080015 Expired
NHGRI E-275-2015-0-US-05 GENE THERAPY FOR COMBINED METHYLMALONIC ACIDEMIA/ACIDURIA AND HYPERHOMOCYSTEINEMIA/HOMOCYSTINURIA, COBALAMIN C TYPE, AND DEFICIENCY OF MMACHC US DIV 18/056,356 Pending
NIA E-135-2022-1-US-01 MONOCLONAL ANTIBODIES DIRECTED TO PHOSPHORYLATED PSD95 AND USES THEREOF US 63/426,275 Expired
NIAID E-128-2021-0-EP-01 COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS EP National Stage 21803062.5 Pending
NCI E-027-2023-0-US-01 REAL-TIME REMOTE CONTROLLED MICROSCOPY AND COMMUNICATIONS OVER A NETWORK US 63/425,888 Expired
NCI E-184-2020-0-US-03 TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS US National Stage 17/925,582 Pending
NCATS E-101-2017-0-EP-07 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS EP DIV 22207287.8 Issued
NIAID E-128-2021-0-US-02 COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS US National Stage 17/998,752 Pending
NLM E-125-2017-2-US-06 CRYSTAL STRUCTURE OF CRISPR CPF1 US CON 17/986,277 Pending
NIAID E-064-2016-1-CN-10 RSV F IMMUNOGENS AND THEIR USE CN DIV 202211420259.2 Pending
NIAID E-171-2021-0-PCT-02 SARS-COV-2 SPIKE FUSED TO HEPATITIS B SURFACE ANTIGEN PCT PCT PCT/US2022/079750 Expired
NIAID E-104-2020-0-US-08 RSV VACCINE BEARING ONE OR MORE P GENE MUTATIONS US National Stage 17/924,784 Pending
NCI E-219-2022-0-US-01 Circulating MicroRNA (miRNA) Markers To Diagnose Lethal Radiation
(WRAIR 22-05-US01-PR1) 		US 63/424,554 Expired
NICHD E-151-2021-0-PCT-02 NUCLEAR MAGNETIC RESONANCE METHODS OF DETERMINING HOMEOSTATIC
PERTURBATIONS 		PCT PCT PCT/US2022/049542 Expired
NEI E-058-2018-0-US-08 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES (2-D CELLS AND 3-D TISSUES) FOR USE IN CELL THERAPY AND TISSUE ENGINEERED PRODUCTS US CON 17/983,963 12020494 Issued PDF
NCI E-205-2021-0-PCT-02 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF PCT PCT PCT/US2022/079554 Expired
NCI E-205-2021-0-CN-01 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF CN National Stage 202280088358.7 Pending
NHLBI E-166-2022-0-US-01 MYOTOMY CATHETER SYSTEM AND METHODS FOR A MYOTOMY CATHETER SYSTEM US 63/383,012 Expired
NCI E-017-2023-0-US-01 Directed acetylation of mRNA through engineered snoRNA adapters US 63/423,714 Expired
NIAID E-251-2020-0-US-02 PPMO Targeting SARS-CoV-2 Genomic RNA To Treat And Prevent Coronavirus Infection US CIP 18/053,308 Pending
NCI E-009-2023-0-US-01 Implications of CXCR3 Expression on Myeloid Cells for Immunotherapy of Cancer and Myeloid-mediated Disease US 63/423,029 Expired
NCI E-099-2014-0-JP-01 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF JP DIV 2022-177351 Issued
NIAID E-095-2021-0-PCT-02 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE PCT PCT PCT/US2022/079340 Expired
NHGRI E-054-2020-0-US-03 ABERRANT POST-TRANSLATIONAL MODIFICATIONS(PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS US National Stage 17/923,394 Pending